Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - AEROSOL, METERED;RECTAL - 10%
USFDA APPLICATION NUMBER - 17351
DOSAGE - CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/G...DOSAGE - CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50218
DOSAGE - SUSPENSION/DROPS;OTIC - EQ 3MG BASE/...DOSAGE - SUSPENSION/DROPS;OTIC - EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML
USFDA APPLICATION NUMBER - 50356
DOSAGE - AEROSOL, METERED;TOPICAL - 1%;1%
USFDA APPLICATION NUMBER - 86195
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Beneo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]BioSpectra
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Doshion Polyscience
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Symrise
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Coating Systems & Additives
Solubilizers
Thickeners and Stabilizers
Controlled & Modified Release
Fillers, Diluents & Binders
Parenteral
Film Formers & Plasticizers
Emulsifying Agents
Taste Masking
Granulation
Surfactant & Foaming Agents
Direct Compression
Lubricants & Glidants
Rheology Modifiers
Co-Processed Excipients
API Stability Enhancers
Chewable & Orodispersible Aids
Empty Capsules
Vegetarian Capsules
Coloring Agents
Disintegrants & Superdisintegrants
Soft Gelatin
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
56
PharmaCompass offers a list of Hydrocortisone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydrocortisone Acetate manufacturer or Hydrocortisone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydrocortisone Acetate manufacturer or Hydrocortisone Acetate supplier.
PharmaCompass also assists you with knowing the Hydrocortisone Acetate API Price utilized in the formulation of products. Hydrocortisone Acetate API Price is not always fixed or binding as the Hydrocortisone Acetate Price is obtained through a variety of data sources. The Hydrocortisone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ORABASE HCA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ORABASE HCA, including repackagers and relabelers. The FDA regulates ORABASE HCA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ORABASE HCA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ORABASE HCA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ORABASE HCA supplier is an individual or a company that provides ORABASE HCA active pharmaceutical ingredient (API) or ORABASE HCA finished formulations upon request. The ORABASE HCA suppliers may include ORABASE HCA API manufacturers, exporters, distributors and traders.
click here to find a list of ORABASE HCA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ORABASE HCA DMF (Drug Master File) is a document detailing the whole manufacturing process of ORABASE HCA active pharmaceutical ingredient (API) in detail. Different forms of ORABASE HCA DMFs exist exist since differing nations have different regulations, such as ORABASE HCA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ORABASE HCA DMF submitted to regulatory agencies in the US is known as a USDMF. ORABASE HCA USDMF includes data on ORABASE HCA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ORABASE HCA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ORABASE HCA suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The ORABASE HCA Drug Master File in Japan (ORABASE HCA JDMF) empowers ORABASE HCA API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the ORABASE HCA JDMF during the approval evaluation for pharmaceutical products. At the time of ORABASE HCA JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of ORABASE HCA suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ORABASE HCA Drug Master File in Korea (ORABASE HCA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ORABASE HCA. The MFDS reviews the ORABASE HCA KDMF as part of the drug registration process and uses the information provided in the ORABASE HCA KDMF to evaluate the safety and efficacy of the drug.
After submitting a ORABASE HCA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ORABASE HCA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ORABASE HCA suppliers with KDMF on PharmaCompass.
A ORABASE HCA CEP of the European Pharmacopoeia monograph is often referred to as a ORABASE HCA Certificate of Suitability (COS). The purpose of a ORABASE HCA CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of ORABASE HCA EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of ORABASE HCA to their clients by showing that a ORABASE HCA CEP has been issued for it. The manufacturer submits a ORABASE HCA CEP (COS) as part of the market authorization procedure, and it takes on the role of a ORABASE HCA CEP holder for the record. Additionally, the data presented in the ORABASE HCA CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the ORABASE HCA DMF.
A ORABASE HCA CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. ORABASE HCA CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of ORABASE HCA suppliers with CEP (COS) on PharmaCompass.
A ORABASE HCA written confirmation (ORABASE HCA WC) is an official document issued by a regulatory agency to a ORABASE HCA manufacturer, verifying that the manufacturing facility of a ORABASE HCA active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting ORABASE HCA APIs or ORABASE HCA finished pharmaceutical products to another nation, regulatory agencies frequently require a ORABASE HCA WC (written confirmation) as part of the regulatory process.
click here to find a list of ORABASE HCA suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ORABASE HCA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ORABASE HCA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ORABASE HCA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ORABASE HCA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ORABASE HCA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ORABASE HCA suppliers with NDC on PharmaCompass.
ORABASE HCA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ORABASE HCA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ORABASE HCA GMP manufacturer or ORABASE HCA GMP API supplier for your needs.
A ORABASE HCA CoA (Certificate of Analysis) is a formal document that attests to ORABASE HCA's compliance with ORABASE HCA specifications and serves as a tool for batch-level quality control.
ORABASE HCA CoA mostly includes findings from lab analyses of a specific batch. For each ORABASE HCA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ORABASE HCA may be tested according to a variety of international standards, such as European Pharmacopoeia (ORABASE HCA EP), ORABASE HCA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ORABASE HCA USP).
